SFI
AVXL icon

Susquehanna Fundamental Investments’s Anavex Life Sciences AVXL Stock Holding History

Susquehanna Fundamental Investments’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-17,120
Closed -$297K – 1534
2021
Q4 		$297K Hold
17,120
– – 0.01% 1119
2021
Q3 		$307K Sell
17,120
-13,633
-44% -$271K 0.01% 1402
2021
Q2 		$703K Hold
30,753
– – 0.01% 1023
2021
Q1 		$460K Buy
30,753
+17,120
+126% +$187K 0.01% 1171
2020
Q4 		$74K Sell
13,633
-15,100
-53% -$79.6K ﹤0.01% 1437
2020
Q3 		$131K Buy
+28,733
New +$124K ﹤0.01% 1252

Other funds holding AVXL

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $606M AUM 63.41% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Susquehanna Fundamental Investments's AVXL Position: Q1 2022 in Review

Susquehanna Fundamental Investments sold out of Anavex Life Sciences (AVXL) in Q1 2022, closing a stake of 17,120 shares — an estimated $297K sold.

Susquehanna Fundamental Investments first reported a position in AVXL in Q3 2020 and held it in 6 quarters. The position peaked at $703K in Q2 2021. 139 funds tracked by Wall St. Rank hold AVXL as of Q1 2022.

  • Susquehanna Fundamental Investments reported no remaining Anavex Life Sciences position as of Q1 2022 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 17,120 Anavex Life Sciences shares in Q1 2022, an estimated $297K.
  • Susquehanna Fundamental Investments first reported a position in Anavex Life Sciences in Q3 2020 and held it in 6 quarters.
  • Susquehanna Fundamental Investments's Anavex Life Sciences position peaked at $703K in Q2 2021.
  • 139 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2022, filed 16 May 2022.